Loxo Oncology, Inc. Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
Loxo Oncology, Inc. reported Increase (Decrease) in Other Accounts Payable and Accrued Liabilities of $21.20 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities · last filed 2018-11-08
- Loxo Oncology, Inc. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2018-09-30 was $9.35M, a 41.01% increase year-over-year.
- Loxo Oncology, Inc. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2018-06-30 was $11.84M.
- Loxo Oncology, Inc. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2018-03-31 was $9.00K.
- Loxo Oncology, Inc. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2017-12-31 was $6.90M, a 18.39% decline year-over-year.
- Loxo Oncology, Inc. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2017 was $8.45M, a 26.48% decline from fiscal 2016.
- Loxo Oncology, Inc. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2016 was $11.50M, a 971.67% increase from fiscal 2015.
- Loxo Oncology, Inc. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2015 was $1.07M, a 5.55% decline from fiscal 2014.
- Loxo Oncology, Inc. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2014 was $1.14M.
| Period end | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2018-09-30 | $9.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $21.19M derived: sum of 2 quarters · filed 2018-11-08 | $21.20M 10-Q · filed 2018-11-08 | $28.10M derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-06-30 | $11.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $11.85M 10-Q · filed 2018-08-09 | $18.75M derived: sum of 3 quarters · filed 2018-08-09 | $25.38M derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-03-31 | $9.00K 10-Q · filed 2018-05-08 | $6.91M derived: sum of 2 quarters · filed 2018-05-08 | $13.54M derived: sum of 3 quarters · filed 2018-11-08 | $13.39M derived: sum of 4 quarters · filed 2018-11-08 |
| 2017-12-31 | $6.90M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $13.53M derived: sum of 2 quarters · filed 2018-11-08 | $13.38M derived: sum of 3 quarters · filed 2018-11-08 | $8.45M 10-K · filed 2018-03-01 |
| 2017-09-30 | $6.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $6.49M derived: sum of 2 quarters · filed 2018-11-08 | $1.56M 10-Q · filed 2018-11-08 | $10.01M derived: sum of 4 quarters · filed 2018-11-08 |
| 2017-06-30 | -$147.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$5.08M 10-Q · filed 2018-08-09 | $3.38M derived: sum of 3 quarters · filed 2018-08-09 | $3.89M derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | -$4.93M 10-Q · filed 2018-05-08 | $3.52M derived: sum of 2 quarters · filed 2018-05-08 | $4.04M derived: sum of 3 quarters · filed 2018-05-08 | $7.01M derived: sum of 4 quarters · filed 2018-05-08 |
| 2016-12-31 | $8.45M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $8.96M derived: sum of 2 quarters · filed 2018-03-01 | $11.94M derived: sum of 3 quarters · filed 2018-03-01 | $11.50M 10-K · filed 2018-03-01 |
| 2016-09-30 | $514.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $3.49M derived: sum of 2 quarters · filed 2017-11-02 | $3.05M 10-Q · filed 2017-11-02 | $3.52M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $2.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $2.54M 10-Q · filed 2017-08-08 | $3.01M derived: sum of 3 quarters · filed 2018-03-01 | $3.72M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | -$437.00K 10-Q · filed 2017-05-09 | $39.00K derived: sum of 2 quarters · filed 2018-03-01 | $744.00K derived: sum of 3 quarters · filed 2018-03-01 | $1.16M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $476.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $1.18M derived: sum of 2 quarters · filed 2018-03-01 | $1.60M derived: sum of 3 quarters · filed 2018-03-01 | $1.07M 10-K · filed 2018-03-01 |
| 2015-09-30 | $705.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $1.12M derived: sum of 2 quarters · filed 2016-11-02 | $597.00K 10-Q · filed 2016-11-02 | $1.57M derived: sum of 4 quarters · filed 2017-03-07 |
| 2015-06-30 | $416.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | -$108.00K 10-Q · filed 2016-08-03 | $865.00K derived: sum of 3 quarters · filed 2017-03-07 | |
| 2015-03-31 | -$524.00K 10-Q · filed 2016-05-04 | $449.00K derived: sum of 2 quarters · filed 2017-03-07 | ||
| 2014-12-31 | $973.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07 | $1.14M 10-K · filed 2017-03-07 | ||
| 2014-09-30 | $163.00K 10-Q · filed 2015-11-10 |